Related Experiment Video

Updated: Jul 17, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Systemic immune dysfunction in pancreatic cancer patients

Bertram Poch1, Errki Lotspeich, Marco Ramadani

  • 1Center for Oncological, Endocrinological and Minimal-access Surgery, Silcherstr. 36, 89231 Neu-Ulm, Germany.

Langenbeck'S Archives of Surgery
|January 20, 2007
PubMed

Insights

Pancreatic cancer patients exhibit systemic immune dysfunction, with reduced lymphocyte response to stimulation and altered cytokine profiles. This immune dysregulation is a key characteristic of the disease.

Area of Science:

  • Immunology
  • Oncology

Background:

  • Pancreatic cancer (PC) is associated with complex immune alterations.
  • Understanding the immune status in PC patients is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the immune status of pancreatic cancer patients compared to healthy controls.
  • To characterize peripheral blood lymphocyte (PBL) populations and their responses.
  • To analyze serum cytokine levels in PC patients.

Main Methods:

  • Flow cytometry was used to analyze PBL subsets (CD4+, CD8+, CD19+, CD56+).
  • Blastogenic response of PBL was assessed after stimulation with mitogens (ConA, PHA, PWM) and anti-CD3 antibodies.
  • Serum levels of various cytokines (TNF-alpha, IL-1beta, IL-2, IL-10, IL-12, IL-18, IL-1RA, sIL-2R, TGF-beta) were measured using ELISA.

Main Results:

  • No significant differences in peripheral immunocyte distribution were observed between PC patients and healthy controls.
  • PC patients showed a significantly decreased blastogenic response of PBL to PHA and anti-CD3 stimulation.
  • Elevated serum levels of TNF-alpha, TGF-beta1, IL-10, IL-2R, IL-1beta, and IL-1RA were found in PC patients, along with reduced IL-2 levels.

Conclusions:

  • Pancreatic cancer is characterized by systemic immune dysfunction.
  • A shift towards a T helper cell type 2 cytokine profile and elevated levels of T cell suppressive substances were observed.
  • Reduced PBL blastogenic response to PHA and anti-CD3 indicates impaired cellular immunity in PC.
Abstract

More Related Videos

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry08:30

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Concept Videos

Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: